Cargando…

Hydroxychloroquine/remdesivir/tocilizumab: Increase in corrected QT interval and off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498996/ http://dx.doi.org/10.1007/s40278-020-83509-2

Ejemplares similares

Azithromycin/hydroxychloroquine: Corrected QT-interval prolongation following off label use: case report
Publicado: (2020)

Hydroxychloroquine: Prolonged QT interval following off label use: case report
Publicado: (2020)

Hydroxychloroquine: QT interval prolongation following off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: Prolonged QT interval during off label use: case report
Publicado: (2021)

Ceftriaxone/hydroxychloroquine/tocilizumab: QT prolongation, torsade-de-pointes and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine interaction: QT interval prolongation following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: Electrical storm and QT interval prolongation following off-label use: case report
Publicado: (2020)

Multiple drugs: Increased corrected QT interval and off label use: case report
Publicado: (2021)

Remdesivir/tocilizumab: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/remdesivir/tocilizumab: Methaemoglobinaemia and off-label use: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolonged corrected QT following off label use: case report.
Publicado: (2020)

Hydroxychloroquine: QT prolongation due to off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: Lengthening of the QT interval, bradycardia and atrioventricular block following an off-label use: case report
Publicado: (2020)

Remdesivir/tocilizumab: Drug ineffective and off-label use: 2 case reports
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Lack of efficacy and off label use: case report
Publicado: (2021)

Dexamethasone/remdesivir/tocilizumab: Off-label use and lack of efficacy: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine/tocilizumab: QTc prolongation and off label use: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: QT prolongation following off label use: case report
Publicado: (2022)

Hydroxychloroquine: Persistent increase in QTc interval following off-label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: QT-interval prolongation and polymorphic ventricular tachycardia arrest due to off-label use: 2 case reports
Publicado: (2021)

Azithromycin/favipiravir/hydroxychloroquine interactions: Corrected QT (QTc) interval prolongation due to pharmacodynamic interaction following off label use: 2 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Chloroquine: Prolonged corrected QT interval following off label use: 2 case reports
Publicado: (2021)

Hydroxychloroquine/tocilizumab: Cytomegalovirus enterocolitis and hypovolaemic-shock following off-label use: case report
Publicado: (2020)

Hydroxychloroquine/lopinavir/ritonavir/tocilizumab: Lack of efficacy following off label use: case report
Publicado: (2022)

Azithromycin/hydroxychloroquine: QT prolongation and ventricular extrasystole secondary to off label use: case report
Publicado: (2021)

Hydroxychloroquine: Corrected QT interval prolongation, first degree atrioventricular block and left bundle branch block during an off-label treatment with hydroxychloroquine for COVID-19 pneumonia: 3 case reports
Publicado: (2020)

Hydroxychloroquine: Prolonged QTc interval following off-label use: case report
Publicado: (2020)

Hydroxychloroquine: QTc interval prolonged following off label use: case report
Publicado: (2021)

Epoprostenol/hydroxychloroquine/tocilizumab: Acute large bowel perforation, off-label use and lack of efficacy: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine/lopinavir/ritonavir: Complete atrioventricular-block, torsades-de-pointes and QT-interval-prolongation following off label use: 2 case reports
Publicado: (2020)

Hydroxychloroquine: Borderline prolongation of QTc interval during off-label treatment: case report
Publicado: (2020)

Meropenem/moxifloxacin/umifenovir: QT interval prolongation and off label use: 2 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine: QT prolongation with a notched broad T-wave following off-label therapy: case report
Publicado: (2020)

Tocilizumab: Off-label use and neutropenia: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation and torsades de pointes following off-label use: case report
Publicado: (2020)

Tocilizumab: Candidaemia and Off-label-use: 3 case reports
Publicado: (2020)

Tocilizumab: Acute hypertriglyceridaemia and off-label use: case report
Publicado: (2020)

Tocilizumab: Off label use and lack of efficacy: case report
Publicado: (2021)

Tocilizumab: Anaphylaxis following off-label use: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fgcr1bgeq208tksd919rgktbol